Thymus histology and concomitant autoimmune diseases in Japanese patients with muscle-specific receptor tyrosine kinase-antibody-positive myasthenia gravis

被引:19
|
作者
Nakata, R. [1 ]
Motomura, M. [1 ]
Masuda, T. [1 ]
Shiraishi, H. [1 ]
Tokuda, M. [1 ]
Fukuda, T. [1 ]
Ando, T. [1 ]
Yoshimura, T. [1 ]
Tsujihata, M. [2 ,3 ]
Kawakami, A. [1 ]
机构
[1] Nagasaki Univ, Dept Clin Neurosci & Neurol, Grad Sch Biomed Sci, Nagasaki 8528501, Japan
[2] Nagasaki Univ, Sch Hlth Sci, Nagasaki 8528501, Japan
[3] Nagasaki Kita Hosp, Nagasaki, Japan
关键词
associated autoimmune disease; muscle-specific receptor tyrosine kinase; myasthenia gravis; thymus; titin antibodies; TITIN ANTIBODIES; ACETYLCHOLINE-RECEPTORS; MYOID CELLS; MUSK; AUTOANTIBODIES; THYMOMA; HETEROGENEITY; FEATURES; MG;
D O I
10.1111/ene.12169
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and purpose: The differences in the characteristics of thymus histology, coexisting autoimmune diseases and related autoantibodies between anti-muscle-specific receptor tyrosine kinase (MuSK)-antibody (Ab)-positive myasthenia gravis (MG) patients, and anti-acetylcholine receptor (AChR)-Ab-positive MG patients are not clearly defined. Methods: The types of thymus histology, coexisting autoimmune diseases and associated Abs in 83 MuSK-Ab-positive patients nationwide were investigated and were compared with those in AChR-Ab-positive patients followed at our institute (n = 83). As for the autoantibodies associated with thymoma, titin Abs were measured. Results: Thymoma was not present in any of the MuSK-Ab-positive patients but presented in 21 patients (25.3%) amongst the AChR-Ab-positive patients. Titin Abs were absent in MuSK-Ab-positive patients but positive in 25 (30.1%) of the AChR-Ab-positive patients. Concomitant autoimmune diseases were present in eight MuSK-Ab-positive patients (9.6%) amongst whom Hashimoto's thyroiditis and rheumatoid arthritis predominated, whereas 22 AChR-Ab-positive patients (26.5%) had one or more concomitant autoimmune diseases of which Graves' disease predominated. Conclusions: Differences in frequency of thymoma and thymic hyperplasia, coexisting autoimmune diseases and autoantibody positivity between MuSK-Ab-positive and AChR-Ab-positive MG were indicated, suggesting that, in contrast with AChR-Ab-positive MG, thymus does not seem to be involved in the pathogenic mechanisms of MuSK-Ab-positive MG.
引用
收藏
页码:1272 / 1276
页数:5
相关论文
共 50 条
  • [21] Muscle-Specific Kinase Autoimmune Myasthenia Gravis: Report of a Pediatric Case and Literature Review
    Ben Younes, Thouraya
    Benrhouma, Hanene
    Klaa, Hedia
    Ben Aoun, Rania
    Rouissi, Aida
    Ben Ahmed, Melika
    Kraoua, Ichraf
    Youssef-Turki, Ilhem
    NEUROPEDIATRICS, 2019, 50 (02) : 116 - 121
  • [22] Prevalence and course of muscle-specific receptor tyrosine kinase (MuSK) antibodies in myasthenia gravis-A retrospective study
    Stahl, Jan-Hendrik
    Konle, Max
    Kowarik, Markus
    Dubois, Evelyn
    Armbruster, Marcel
    Kleiser, Benedict
    Grimm, Alexander
    Martin, Pascal
    Marquetand, Justus
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2025, 472
  • [23] Development of a highly sensitive diagnostic assay for muscle-specific tyrosine kinase (MuSK) autoantibodies in myasthenia gravis
    Trakas, Nikolaos
    Zisimopoulou, Paraskevi
    Tzartos, Socrates J.
    JOURNAL OF NEUROIMMUNOLOGY, 2011, 240 : 79 - 86
  • [24] Muscle-specific kinase antibody associated myasthenia gravis after bone marrow transplantation
    Heidarzadeh, Zeinab
    Mousavi, Seyyed-Asadollah
    Ostovan, Vahid Reza
    Nafissi, Shahriar
    NEUROMUSCULAR DISORDERS, 2014, 24 (02) : 148 - 150
  • [25] Short-term effect of low-dose rituximab on myasthenia gravis with muscle-specific tyrosine kinase antibody
    Zhou, Yufan
    Yan, Chong
    Gu, Xinyu
    Zhou, Lei
    Lu, Jun
    Zhu, Wenhua
    Huan, Xiao
    Luo, Sushan
    Zhong, Huahua
    Lin, Jie
    Lu, Jiahong
    Zhao, Chongbo
    Xi, Jianying
    MUSCLE & NERVE, 2021, 63 (06) : 824 - 830
  • [26] Report of the ASFA apheresis registry on muscle specific kinase antibody positive myasthenia gravis
    Yamada, Chisa
    Pham, Huy P.
    Wu, Yanyun
    Cooling, Laura
    Kim, Haewon C.
    Morgan, Shanna
    Schwartz, Joseph
    Winters, Jeffrey L.
    Wong, Edward C. C.
    JOURNAL OF CLINICAL APHERESIS, 2017, 32 (01) : 5 - 11
  • [27] Single-fiber electromyography in limb and facial muscles in muscle-specific kinase antibody and acetylcholine receptor antibody myasthenia gravis
    Farrugia, ME
    Kennett, RP
    Newsom-Davis, J
    Hilton-Jones, D
    Vincent, A
    MUSCLE & NERVE, 2006, 33 (04) : 568 - 570
  • [28] Muscle-specific regulation of the mTOR signaling pathway in MuSK antibody seropositive (MuSK plus ) experimental autoimmune Myasthenia gravis (EAMG)
    Chauhan, Mayank
    Punga, Tanel
    Punga, Anna Rostedt
    NEUROSCIENCE RESEARCH, 2013, 77 (1-2) : 102 - 109
  • [29] Characterization of pathogenic monoclonal autoantibodies derived from muscle-specific kinase myasthenia gravis patients
    Takata, Kazushiro
    Stathopoulos, Panos
    Cao, Michelangelo
    Mane-Damas, Marina
    Fichtner, Miriam L.
    Benotti, Erik S.
    Jacobson, Leslie
    Waters, Patrick
    Irani, Sarosh R.
    Martinez-Martinez, Pilar
    Beeson, David
    Losen, Mario
    Vincent, Angela
    Nowak, Richard J.
    O'Connor, Kevin C.
    JCI INSIGHT, 2019, 4 (12)
  • [30] Use of rituximab in muscle-specific tyrosine kinase antibody-positive myasthenia gravis: Preliminary observations from a tertiary care center in Northern India
    Sachdeva, Julie
    Mahesh, Karthik Vinay
    Shree, Ritu
    Jain, Gaurav
    Kapila, Aastha Takkar
    Shashikala, Tirulapati Shashikala
    Goyal, Manoj Goyal
    Modi, Manish
    Lal, Vivek
    INDIAN JOURNAL OF PHARMACOLOGY, 2020, 52 (01) : 49 - 52